American Research & Management Has Upped Its Edwards Lifesciences (EW) Holding, Dial (DL)’s Sentiment Is 1

July 25, 2017 - By Migdalia James

China Distance Education Holdings Limited is a holding company. The company has market cap of $264.22 million. The Firm is engaged in providing online and offline education services, and selling related products in the People’s Republic of China . It has a 10.29 P/E ratio. The Company’s divisions include online education services, business start-up training services and the sale of learning simulation software.

American Research & Management increased Edwards Lifesciences (EW) stake by 205.81% reported in 2016Q4 SEC filing. American Research & Management acquired 4,425 shares as Edwards Lifesciences (EW)’s stock rose 25.80%. The American Research & Management holds 6,575 shares with $616,000 value, up from 2,150 last quarter. Edwards Lifesciences now has $24.29B valuation. The stock decreased 0.74% or $0.87 during the last trading session, reaching $117.14. About shares traded. Edwards Lifesciences Corp (NYSE:EW) has risen 15.41% since July 25, 2016 and is uptrending. It has underperformed by 1.29% the S&P500.

The stock increased 0.89% or $0.07 on July 24, reaching $7.9. About shares traded. China Distance Education Hldgs Ltd (ADR) (DL) has declined 28.21% since July 25, 2016 and is downtrending. It has underperformed by 44.91% the S&P500.

Herald Investment Management Ltd holds 1% of its portfolio in China Distance Education Hldgs Ltd (ADR) for 206,473 shares. Sensato Investors Llc owns 356,651 shares or 0.69% of their US portfolio. Moreover, Jupiter Asset Management Ltd has 0.34% invested in the company for 818,424 shares. The Bermuda-based Fil Ltd has invested 0.05% in the stock. Van Berkom & Associates Inc., a Quebec – Canada-based fund reported 78,416 shares.

Among 25 analysts covering Edwards Lifesciences Corp (NYSE:EW), 19 have Buy rating, 1 Sell and 5 Hold. Therefore 76% are positive. Edwards Lifesciences Corp had 66 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co on Wednesday, April 27 with “Outperform”. Jefferies maintained the stock with “Buy” rating in Monday, April 4 report. JMP Securities reinitiated the shares of EW in report on Wednesday, January 6 with “Mkt Perform” rating. The stock has “Neutral” rating by Suntrust Robinson on Friday, January 8. The rating was initiated by UBS on Tuesday, September 22 with “Buy”. The rating was downgraded by Zacks to “Hold” on Tuesday, September 22. The stock of Edwards Lifesciences Corp (NYSE:EW) has “Equalweight” rating given on Wednesday, July 27 by Barclays Capital. Northland Capital downgraded Edwards Lifesciences Corp (NYSE:EW) on Tuesday, April 5 to “Market Perform” rating. Citigroup maintained the shares of EW in report on Wednesday, July 27 with “Sell” rating. As per Monday, October 19, the company rating was upgraded by Wells Fargo.